A rating of 99 puts Akebia Therapeutics Inc (AKBA) near the top of the Biotechnology industry according to InvestorsObserver. Akebia Therapeutics Inc's score of 99 means it scores higher than 99% of stocks in the industry. Akebia Therapeutics Inc also received an overall rating of 89, putting it above 89% of all stocks. Biotechnology is ranked 73 out of the 148 industries.
AKBA has an Overall Score of 89. Find out what this means to you and get the rest of the rankings on AKBA!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 89 would rank higher than 89 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Akebia Therapeutics Inc Stock Today?
Akebia Therapeutics Inc (AKBA) stock is trading at $1.13 as of 1:18 PM on Wednesday, Oct 4, a gain of $0.08, or 7.14% from the previous closing price of $1.05. The stock has traded between $1.05 and $1.15 so far today. Volume today is low. So far 910,476 shares have traded compared to average volume of 1,408,669 shares.
Click Here to get the full Stock Report for Akebia Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
